NextPlat (NASDAQ:NXPL – Get Free Report) will likely be announcing its Q2 2026 results before the market opens on Wednesday, August 12th. Analysts expect NextPlat to announce earnings of ($0.21) per share and revenue of $11.00 million for the quarter. Individuals may review the information on the company’s upcoming Q2 2026 earning results page for the latest details on the call scheduled for Thursday, August 13, 2026 at 8:30 AM ET.
NextPlat (NASDAQ:NXPL – Get Free Report) last posted its quarterly earnings results on Thursday, May 14th. The company reported ($0.42) earnings per share for the quarter. The company had revenue of $9.86 million for the quarter. NextPlat had a negative net margin of 23.14% and a negative return on equity of 58.05%. On average, analysts expect NextPlat to post $-1 EPS for the current fiscal year and $1 EPS for the next fiscal year.
NextPlat Stock Down 0.2%
NXPL opened at $6.09 on Wednesday. NextPlat has a twelve month low of $3.38 and a twelve month high of $11.10. The company’s 50-day moving average price is $6.46 and its two-hundred day moving average price is $5.98. The stock has a market cap of $16.50 million, a price-to-earnings ratio of -1.41 and a beta of 1.83. The company has a quick ratio of 2.12, a current ratio of 2.56 and a debt-to-equity ratio of 0.05.
Analyst Upgrades and Downgrades
View Our Latest Stock Report on NXPL
Hedge Funds Weigh In On NextPlat
An institutional investor recently bought a new stake in NextPlat stock. Citadel Advisors LLC acquired a new position in shares of NextPlat Corp. (NASDAQ:NXPL – Free Report) during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 48,176 shares of the company’s stock, valued at approximately $40,000. Citadel Advisors LLC owned approximately 0.19% of NextPlat as of its most recent filing with the Securities and Exchange Commission. Hedge funds and other institutional investors own 1.30% of the company’s stock.
About NextPlat
NextPlat Corp operates as a healthcare and e-commerce company in Europe, North America, South America, the Asia and Pacific, and Africa. The company operates full-service retail specialty services pharmacies that provides prescription pharmaceuticals prescription pharmaceuticals, third-party administration, risk and data management services, compounded medications, tele-pharmacy services, anti-retroviral medications, medication therapy management, contracted pharmacy services, and health practice risk management to healthcare organizations and providers, as well as supplies prescription medications to long-term care facilities.
Read More
- Five stocks we like better than NextPlat
- Caterpillar’s Record Quarter May Have Reset the Stock’s Ceiling
- The Real Reason Amazon Hit a $3 Trillion Valuation
- System Upgrade: First Internet Bancorp Options Surge
- AI Security Breaches Raise New Risks for Microsoft and Amazon’s Agent Push
Receive News & Ratings for NextPlat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NextPlat and related companies with MarketBeat.com's FREE daily email newsletter.
